Skip to main content
Premium Trial:

Request an Annual Quote

IBM, CLC Bio Team on Sequencing Analytics

NEW YORK (GenomeWeb News) – IBM and CLC Bio announced today that they will offer a trunkey next-generation sequencing data analytics solution that combines their respective products.

The offering will combine IBM hardware, including its System x 3550 M4 rack servers, CLC's Genomics Server software for large-scale genomics sequencing data analysis, and CLC's Genomics Workbench for analyzing, comparing, and visualizing high-throughput sequencing data.

"It is imperative that we serve our customers with a platform that is easy to deploy and support, delivering the power to perform their next generation sequencing workload," Janis Landry-Lane, director of worldwide deep computing at IBM, said in a statement. "Molecular biologists and clinicians need these tools to realize the promise of personalized medicine."

The turnkey platform comes in three different configurations, the firms said, ranging from 48 CPU cores and 192 GBs of memory to 192 CPU cores and 768 GBs of memory, depending on the requirements of the individual customer.

Further terms of the agreement were not disclosed.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.